OBJECTIVE: To determine the relationship of poor asthma control to bronchodilator response (BDR) phenotypes in children with normal spirometry. STUDY DESIGN: Children with asthma were assessed for clinical indexes of poorly controlled asthma. Pre- and post-bronchodilator spirometry were performed, and the percent BDR was determined. Multivariate logistic regression assessed the relationship of the clinical indices to BDR at ≥ 8%, ≥ 10%, and ≥ 12% BDR thresholds. RESULTS: There were 510 controller naïve children and 169 on controller medication. In the controller naïve population the mean age (± 1 SD) was 9.5 (3.4); 57.1% were male, 85.7% Hispanic. Demographics were similar in both populations. In the adjusted profile, significant clinical relationships were found particularly to positive BDR phenotypes ≥ 10% and ≥ 12% versus negative responses including younger age, (OR 2.0, 2.5; P < .05), atopy (OR 1.9, 2.6; P < .01), nocturnal symptoms in females (OR 3.4, 3.8; P < .01); β₂ agonist use (OR 1.7, 2.8; P < .01); and exercise limitation (OR 2.2, 2.5; P < .01) only in the controller naïve population. CONCLUSIONS: The BDR phenotype ≥ 10% is significantly related to poor asthma control, providing a potentially useful objective tool in controller naïve children even when the pre-bronchodilator spirometry result is normal.
OBJECTIVE: To determine the relationship of poor asthma control to bronchodilator response (BDR) phenotypes in children with normal spirometry. STUDY DESIGN:Children with asthma were assessed for clinical indexes of poorly controlled asthma. Pre- and post-bronchodilator spirometry were performed, and the percent BDR was determined. Multivariate logistic regression assessed the relationship of the clinical indices to BDR at ≥ 8%, ≥ 10%, and ≥ 12% BDR thresholds. RESULTS: There were 510 controller naïve children and 169 on controller medication. In the controller naïve population the mean age (± 1 SD) was 9.5 (3.4); 57.1% were male, 85.7% Hispanic. Demographics were similar in both populations. In the adjusted profile, significant clinical relationships were found particularly to positive BDR phenotypes ≥ 10% and ≥ 12% versus negative responses including younger age, (OR 2.0, 2.5; P < .05), atopy (OR 1.9, 2.6; P < .01), nocturnal symptoms in females (OR 3.4, 3.8; P < .01); β₂ agonist use (OR 1.7, 2.8; P < .01); and exercise limitation (OR 2.2, 2.5; P < .01) only in the controller naïve population. CONCLUSIONS: The BDR phenotype ≥ 10% is significantly related to poor asthma control, providing a potentially useful objective tool in controller naïve children even when the pre-bronchodilator spirometry result is normal.
Authors: Henry A Jenkins; Reubin Cherniack; Stanley J Szefler; Ronina Covar; Erwin W Gelfand; Joseph D Spahn Journal: Chest Date: 2003-10 Impact factor: 9.410
Authors: Alex Marotta; Mary D Klinnert; Marcella R Price; Gary L Larsen; Andrew H Liu Journal: J Allergy Clin Immunol Date: 2003-08 Impact factor: 10.793
Authors: Leonard B Bacharier; Robert C Strunk; David Mauger; Deborah White; Robert F Lemanske; Christine A Sorkness Journal: Am J Respir Crit Care Med Date: 2004-06-01 Impact factor: 21.405
Authors: Ronina A Covar; Stanley J Szefler; Richard J Martin; D A Sundstrom; Philip E Silkoff; James Murphy; David A Young; Joseph D Spahn Journal: J Pediatr Date: 2003-05 Impact factor: 4.406
Authors: Pranab Haldar; Ian D Pavord; Ruth H Green; Dominic E Shaw; Michael A Berry; Michael Thomas; Christopher E Brightling; Andrew J Wardlaw Journal: Am J Respir Crit Care Med Date: 2008-05-14 Impact factor: 21.405
Authors: Watcharoot Kanchongkittiphon; Jonathan M Gaffin; Lianne Kopel; Carter R Petty; Mary E Bollinger; Rachel L Miller; Matthew Perzanowski; Elizabeth C Matsui; Wanda Phipatanakul Journal: Ann Allergy Asthma Immunol Date: 2016-05-26 Impact factor: 6.347
Authors: Stanley P Galant; Hirsh D Komarow; Hye-Won Shin; Salman Siddiqui; Brian J Lipworth Journal: Ann Allergy Asthma Immunol Date: 2017-06 Impact factor: 6.347
Authors: Jacqueline A Pongracic; Rebecca Z Krouse; Denise C Babineau; Edward M Zoratti; Robyn T Cohen; Robert A Wood; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Meyer Kattan; Stephen J Teach; Christine C Johnson; Leonard B Bacharier; James E Gern; Steven M Sigelman; Peter J Gergen; Alkis Togias; Cynthia M Visness; William W Busse; Andrew H Liu Journal: J Allergy Clin Immunol Date: 2016-10 Impact factor: 10.793
Authors: Yixin Shi; Anna S Aledia; Ahramahzd V Tatavoosian; Shruthi Vijayalakshmi; Stanley P Galant; Steven C George Journal: J Allergy Clin Immunol Date: 2011-12-17 Impact factor: 10.793
Authors: Yixin Shi; Ahramahzd V Tatavoosian; Anna S Aledia; Steven C George; Stanley P Galant Journal: Ann Allergy Asthma Immunol Date: 2012-07-04 Impact factor: 6.347
Authors: Devika R Rao; Jonathan M Gaffin; Sachin N Baxi; William J Sheehan; Elaine B Hoffman; Wanda Phipatanakul Journal: J Asthma Date: 2012-06-28 Impact factor: 2.515
Authors: Amelia Licari; Ilaria Brambilla; Alessia Marseglia; Maria De Filippo; Valeria Paganelli; Gian L Marseglia Journal: Front Pediatr Date: 2018-06-19 Impact factor: 3.418